+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia

  • ID: 2881940
  • Report
  • Region: Saudi Arabia
  • 140 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia

Summary

The author has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Saudi Arabia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Saudi Arabia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by the author's team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Saudi Arabia, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (GlaxoSmithKline, Novartis, Pfizer, Tabuk Pharmaceuticals and Saudi Arabian Pharmaceutical Industries & Medical Appliances Corp) and profiles and SWOT analyses of the major players in the medical device market (Cardinal Health, Fujitsu, AstraZeneca, GE Healthcare, and Kimberly-Clark Corporation)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Saudi Arabia
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Saudi Arabia
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities and challenges to growth in the Saudi Arabian healthcare market.
Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Saudi Arabian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Saudi Arabian healthcare market.
Note: Product cover images may vary from those shown
2 of 2
  • Executive Summary
  • Overview of Pharmaceutical Market
  • Overview of Medical Device Market
  • Deals Analysis
  • Porter’s Five Forces Model
  • Market Access
  • Country Healthcare Landscape
  • Opportunities and Challenges
  • Appendix
List of Tables
Table 1: Opportunities in Pharmaceutical and Biotech Clusters, Saudi Arabia, 2019
Table 2: Pharmaceutical Market, Saudi Arabia, Sales of Patented Drug Products by Major Therapeutic Class (%), 2010-2015
Table 3: Medical Device Market, Saudi Arabia, Revenue by Segment
Table 4: Nephrology and Urology Device Market, Saudi Arabia, Revenue ($M) and Market Share (%) of Major Companies, 2017
Table 5: Drug Delivery Devices Market, Saudi Arabia, Revenue ($B) and Market Share (%) of Major Companies, 2017
Table 6: Healthcare IT Market, Saudi Arabia, Revenue ($M) and Market Share (%) of Major Players, 2017
Table 7: Ophthalmic Devices, Saudi Arabia, Revenue ($M) and Market Share (%) of Major Companies, 2017
Table 8: Hospital Supplies Market, Saudi Arabia, Revenue ($M) and Market Share (%) of Major Companies, 2017
Table 9: Market Shares of Health Insurance Companies, Saudi Arabia, 2017
Table 10: Total Performance Target, Saudi Arabia, 2019
Table 11: MDMA Evaluation Fees, Saudi Arabia, 2016
Table 12: License Or Renewal Fee ($), 2019, Saudi Arabia
Table 13: Profit Margin (%), 2019, Saudi Arabia
Table 14: Customs Ports, 2015, Saudi Arabia
Table 15: Patent Fees ($), 2019, Saudi Arabia
Table 16: Trademark Fees ($), 2019, Saudi Arabia
Table 17: Label of a Pharmaceutical Product, Saudi Arabia, 2019
Table 18: Minimum Particulars to Appear on Blisters or Strips , Saudi Arabia, 2019
Table 19: Minimum Particulars to Appear on Small Immediate Packaging, Saudi Arabia, 2019
Table 20: Recommendations for Using Color, Saudi Arabia
Table 21: Recommendations for Primary Packaging, Saudi Arabia
Table 22: Recommendations for Secondary Packaging, Saudi Arabia

List of Figures
Figure 1: Pharmaceutical Market, Saudi Arabia, Revenue ($B), 2013-2018
Figure 2: Medical Device Market, Saudi Arabia, Revenue ($B), 2015-2020
Figure 3: Number of Deals (2018-2019)
Figure 4: 2018-19 Deal Overview By Region
Figure 5: Country Profile, Saudi Arabia, 2018
Figure 6: Pharmaceutical Market, Saudi Arabia, Revenue ($B), 2011-2018
Figure 7: Pharmaceutical Market, Saudi Arabia, Revenue Forecast ($B), 2019-2025
Figure 8: Pharmaceutical Market, Saudi Arabia, Pharmaceutical Exports
Figure 9: Pharmaceutical Market, Saudi Arabia, Top Export Partners
Figure 10: Pharmaceutical Market, Saudi Arabia, Pharmaceutical Imports
Figure 11: Pharmaceutical Market, Saudi Arabia, Top Import Partners
Figure 12: Innovation Centers, Saudi Arabia, 2019
Figure 13: Biosimilars, Saudi Arabia, 2019
Figure 14: Major OTC Drug Classes (Share %), Saudi Arabia, 2018
Figure 15: Pharmaceutical Market, Supply Chain, Saudi Arabia
Figure 16: Pharmaceutical Market, Saudi Arabia, Sales of Patented Drug Products by Major Therapeutic Class, 2010-2015
Figure 17: Pharmaceutical Market, Major Players, Saudi Arabia
Figure 18: Medical Device Market, Saudi Arabia, Revenue ($B), 2015-2020
Figure 19: Medical Device Market, Saudi Arabia, Revenue Forecast ($B), 2021-2025
Figure 20:Medical Device Market, Saudi Arabia, Revenue by Segment ($B), 2018
Figure 21: Nephrology and Urology Device Market, Saudi Arabia, Revenue ($B), 2015-2022
Figure 22: Nephrology and Urology Device Market, Saudi Arabia, Market Share of Major Players (%), 2017
Figure 23: Drug Delivery Devices Market, Saudi Arabia, Revenue ($B), 2015-2022
Figure 24: Drug Delivery Devices Market, Saudi Arabia, Market Share of Major Players (%), 2017
Figure 25: Healthcare IT Market, Saudi Arabia, Revenue ($B), 2015-2022
Figure 26: Healthcare IT Market, Saudi Arabia, Market Share of Major Players (%), 2017
Figure 27: Ophthalmic Devices, Saudi Arabia, Revenue ($B), 2015-2022
Figure 28: Ophthalmic Devices, Saudi Arabia, Market Share of Major Players (%), 2017
Figure 29: Hospital Supplies Market, Saudi Arabia, Revenue ($B), 2015-2022
Figure 30: Hospital Supplies Market, Saudi Arabia, Market Share of Major Companies (%), 2017
Figure 31: Diagnostic Market, Saudi Arabia, Revenue ($B), 2015-2020
Figure 32: Diagnostic Market, Saudi Arabia, Revenue ($B), 2021-2025
Figure 33: Medical Device Market - Major Players
Figure 34: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Saudi Arabia, 2018-2019
Figure 35: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Saudi Arabia, 2018-2019
Figure 36: M&A Deals by Therapy Area, Pharmaceutical Market, Saudi Arabia, 2018-2019 (by value and by number)
Figure 37: Structure of the Healthcare Sectors, Saudi Arabia
Figure 38: Organizational Chart of Ministry of Health, Saudi Arabia
Figure 39: NTP Strategy to Transform Healthcare, Saudi Arabia, 2018
Figure 40: Formulary Additions, Saudi Arabia
Figure 41: Insurance System of GOSI, Saudi Arabia, 2019
Figure 42: Health Insurance Market, Revenue ($B), Saudi Arabia, 2018
Figure 43: OOP Expenditure (% of total expenditure on health), Saudi Arabia, 2010-2016
Figure 44: Annual Rate of Change (%), Health Price Index, Saudi Arabia, 2010-2018
Figure 45: SFDA, Organizational Structure, Saudi Arabia, 2018
Figure 46: MAA Submission Process, Saudi Arabia
Figure 47: Drug Licensing, Saudi Arabia
Figure 48: Drug Licensing Renewal, Saudi Arabia
Figure 49: Patent Application Process, Saudi Arabia, 2018
Figure 50: Number of Hospitals, Saudi Arabia, 2010-2018
Figure 51: Diagnostic Equipment, Saudi Arabia, 2015-2018
Figure 52: Hospital Beds (per 10,000 population), Saudi Arabia
Figure 53: OBS/Gyn and Pediatric Hospital Beds of MoH (per 10,000 population), Saudi Arabia
Figure 54: Psychiatric Hospital Beds of MoH (per 10,000 population), Saudi Arabia
Figure 55: Life Expectancy (Years), 2010-2018, Saudi Arabia
Figure 56: Immunization Rate (%), 2010-2018, Saudi Arabia
Figure 57: PM2.5 (μg/m3), Saudi Arabia, 2010-2017
Figure 58: CO2 Emissions (Million of Tons), Saudi Arabia, 2010-2018
Figure 59: Physicians (per 10,000 population), Saudi Arabia, 2010-2018
Figure 60: Dentists (per 10,000 population), Saudi Arabia, 2010-2018
Figure 61: Nurses (per 10,000 population), Saudi Arabia, 2010-2018
Figure 62: Pharmacists (per 10,000 population), Saudi Arabia, 2010-2018
Figure 63: Major Causes of Mortality (number of deaths), Saudi Arabia
Figure 64: Major Causes of Male Mortality (number of deaths), Saudi Arabia
Figure 65: Major Causes of Female Mortality (number of deaths), Saudi Arabia
Figure 66: DALYs by Major Disease (‘000), Saudi Arabia
Figure 67: Healthcare Expenditure as Percentage of GDP (%), Saudi Arabia, 2010-2016
Figure 68: Public-Private Share (%), Saudi Arabia, 2010-2016
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll